Cargando…
The effect of alogliptin on pulmonary function in obese patients with type 2 diabetes inadequately controlled by metformin monotherapy
BACKGROUND: To observe the effect of alogliptin combined with metformin on pulmonary function in obese patients with type 2 diabetes inadequately controlled by metformin monotherapy (500 mg, bid po, for at least 3 months), and evaluate its efficacy and safety. METHODS: After a 2-week screening perio...
Autores principales: | Tai, He, Wang, Ming-Yue, Zhao, Yue-Ping, Li, Ling-Bing, Dong, Qian-Yan, Liu, Xin-Guang, Kuang, Jin-Song |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5370803/ https://www.ncbi.nlm.nih.gov/pubmed/27537577 http://dx.doi.org/10.1097/MD.0000000000004541 |
Ejemplares similares
-
The effect of alogliptin on pulmonary function in obese patients with type 2 diabetes inadequately controlled by metformin monotherapy: Erratum
Publicado: (2016) -
Efficacy and safety of dapagliflozin plus saxagliptin vs monotherapy as added to metformin in patients with type 2 diabetes: A meta-analysis
por: Zhuang, Yan, et al.
Publicado: (2020) -
Sitagliptin/Metformin Versus Insulin Glargine Combined With Metformin in Obese Subjects With Newly Diagnosed Type 2 Diabetes
por: Ji, Ming, et al.
Publicado: (2016) -
Causal association of metformin and osteoporosis: A 2-sample Mendelian randomization study
por: Wei, Yong-Kang, et al.
Publicado: (2023) -
Gliclazide monotherapy increases risks of all-cause mortality and has similar risk of acute myocardial infarction and stroke with glimepiride monotherapy in Korean type 2 diabetes mellitus
por: Cho, Eun-Hee, et al.
Publicado: (2020)